Equities

Accuray Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Accuray Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.5123
  • Today's Change-0.043 / -7.68%
  • Shares traded1.61m
  • 1 Year change-77.63%
  • Beta1.1673
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

  • Revenue in USD (TTM)436.97m
  • Net income in USD-35.62m
  • Incorporated2001
  • Employees990.00
  • Location
    Accuray Inc1240 DEMING WAYMADISON 53717United StatesUSA
  • Phone+1 (608) 824-2800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.accuray.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Heartbeam Inc0.00-20.62m45.47m16.00--111.65-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
EUDA Health Holdings Ltd5.16m-2.06m45.75m117.0078.32----8.870.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Spectral AI Inc23.17m-16.37m47.87m78.00------2.07-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Neuraxis Inc3.36m-8.37m49.22m21.00--20.02--14.64-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Sharps Technology Inc2.51m-104.37m49.29m5.00--0.1084--19.62-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Nutriband Inc2.28m-34.59m53.08m13.00--7.02--23.30-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Alpha Pro Tech Ltd59.10m3.68m54.60m130.0015.430.866612.120.92390.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
CS Diagnostics Corp0.00-341.62k55.94m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
Pulmonx Corp91.66m-56.75m59.81m291.00--0.9962--0.6525-1.41-1.412.281.460.59971.477.20314,996.60-37.13-26.27-42.91-28.9673.3072.91-61.91-89.484.15--0.3821--22.0120.787.31--14.98--
Accuray Inc436.97m-35.62m62.89m990.00--1.18--0.1439-0.2982-0.29823.890.47130.94342.105.90441,382.80-7.69-1.60-13.56-2.7227.8335.04-8.15-1.750.7091-0.38320.7178--2.683.6789.77--2.76--
Forian Inc28.11m-852.58k64.94m1.00--2.08--2.31-0.0274-0.02740.90241.000.5692--4.4628,106,910.00-1.73-24.90-2.92-29.2355.4071.84-3.03-67.83----0.00---5.015.68-257.42------
Positron Corp1.24m-1.27m65.70m22.00------53.11-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
QT Imaging Holdings Inc11.50m-19.51m68.70m20.00------5.98-2.09-2.091.27-0.9391.201.346.57574,821.50-204.52---4,313.85--50.81---169.73--0.4745-2.0280.26--11,987.88---132.34------
DarioHealth Corp24.73m-37.11m69.54m196.00--0.9294--2.81-12.47-12.478.2911.070.21732.226.51126,183.70-37.17-63.89-42.41-75.3056.8634.31-171.09-262.344.02-69.690.2901--32.8629.0435.47--7.09--
InspireMD Inc7.78m-46.20m75.21m85.00--1.16--9.67-0.8396-0.83960.1391.530.12071.934.4691,517.65-71.65-60.63-83.34-71.7724.9120.76-593.89-377.986.17--0.00--12.9613.50-60.70--37.62--
Data as of Feb 11 2026. Currency figures normalised to Accuray Inc's reporting currency: US Dollar USD

Institutional shareholders

38.05%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20257.09m6.25%
Albin Kistler AGas of 31 Dec 20245.40m4.76%
Neuberger Berman Investment Advisers LLCas of 30 Sep 20255.28m4.66%
Weber Capital Management LLC (Investment Management)as of 31 Dec 20255.06m4.46%
The Vanguard Group, Inc.as of 31 Dec 20255.02m4.43%
Heartland Advisors, Inc.as of 30 Sep 20255.00m4.41%
Armistice Capital LLCas of 30 Sep 20253.32m2.93%
Geode Capital Management LLCas of 30 Sep 20252.49m2.20%
Renaissance Technologies LLCas of 30 Sep 20252.48m2.19%
SSgA Funds Management, Inc.as of 30 Sep 20251.99m1.76%
More ▼
Data from 31 Dec 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.